MEDINCELL S.A. (MEDCL.PA)

24.04EUR -2.51% (-0.62)

Over 3Y: +227.5%

2026-08-28
10 20 30 40
2023 2024 2025 2026

Figures as at 2026-03-31, reported in EUR. The newest fact in the filings is dated 2026-04-01, 150 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 21.5%
OE margin -126.0%
Oper. margin -85.6%
Accruals -6.2%
FCF margin -104.5%
OCF margin -101.1%
Profit margin -128.9%
ROA -29.0%
ROCE -23.8%
ROE -1021.1%
EBITDA margin —
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/Sales 33.0×
EV/OE -26.2×
P/C 13.7×
FCF yield -2.9%
P/B 281.7×
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.6
ND/EBITDA 0.078
Cash runway 2.5 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 4.7×
Cash / Debt —
F-score —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -12.4%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Shares change —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.